What is the current Price Target for the Brainstorm Cell Therapeutics Inc. stock?

The average Brainstorm Cell Therapeutics Inc. target price is $6.00. This is 435.71% higher than the current stock price. 1 Analyst has issued a Brainstorm Cell Therapeutics Inc. price target 2026.

How high will the Brainstorm Cell Therapeutics Inc. stock rise?

No reliable answer can be given as to how high the Brainstorm Cell Therapeutics Inc. stock will rise. The performance of stocks, including the Brainstorm Cell Therapeutics Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Brainstorm Cell Therapeutics Inc. stock today?

The performance of Brainstorm Cell Therapeutics Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Brainstorm Cell Therapeutics Inc. stock fall?

The decline in Brainstorm Cell Therapeutics Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Brainstorm Cell Therapeutics Inc. Forecast, price target & analysts

$1.11

3.22% yesterday

Nasdaq, Jun 04, 09:39 pm CET

ISIN

US10501E2019

Symbol

BCLI

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Technology

Industry

Computer Hardware

Overview Dividends Analysts Charts News Strategies

Brainstorm Cell Therapeutics Inc. Target price 2025 - Analyst rating & recommendation

Brainstorm Cell Therapeutics Inc. Classifications & Recommendation:

Buy

100%

Brainstorm Cell Therapeutics Inc. Price Target

Target Price	$6.00
Price	$1.12
Potential	435.71% register free of charge
Number of Estimates	1

	1 Analyst has issued a Brainstorm Cell Therapeutics Inc. price target 2026. The average Brainstorm Cell Therapeutics Inc. target price is $6.00. This is 435.71% register free of charge higher than the current stock price.
	A rating was issued by 1 analysts: 1 Analysts recommend Brainstorm Cell Therapeutics Inc. to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Brainstorm Cell Therapeutics Inc. stock has an average upside potential 2026 of 435.71% register free of charge . Most analysts recommend the Brainstorm Cell Therapeutics Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-2.31	-1.60
	61.44%	30.74%
P/E		negative

1 Analysts have issued a Brainstorm Cell Therapeutics Inc. forecast for earnings per share. The average Brainstorm Cell Therapeutics Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-2.31	61.44%
2025	$-1.60 30.74% Unlock
2026	$-0.93 41.88% Unlock
2027	$-0.81 12.90% Unlock
2028	$-0.41 49.38% Unlock
2029	$-0.13 68.29% Unlock

Current	-0.64	68.25%
2025	-0.70 8.75% Unlock
2026	-1.20 71.43% Unlock
2027	-1.38 15.00% Unlock
2028	-2.73 97.83% Unlock
2029	-8.62 215.75% Unlock

Brainstorm Cell Therapeutics Inc....

Discover more stocks with a high price target

TUI 41.65%

Alibaba Group Holding Ltd 38.12%

Novo Nordisk 35.70%

NIO ADR 35.58%

MongoDB 25.55%

Tencent Holdings Ltd. 25.10%

BioNTech SE - ADR 23.86%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now